Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.29NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.29NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AA.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AA.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AA.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BY.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BY.1.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DK.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DK.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.11.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.11.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.11.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.63NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.63NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.63NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FM.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FM.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FM.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.4.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.4.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.4.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.1.10.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.1.10.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.10.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GN.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GN.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GN.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.13.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
FL.13.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.13.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
GW.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GW.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GW.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.424NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.424NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.424NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.64NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.64NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.64NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AH.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AH.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AH.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.327NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.327NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.327NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used